P. LiWang

发表

Pharmaceutical Approaches to HIV Treatment and Prevention

D. Kaplan, C. Herrera, S. Dandekar, 2018, Advanced therapeutics.

Resurrected Ancestors Reveal Origins of Metamorphism in XCL1.

Lee‐Ping Wang, P. LiWang, A. LiWang, 2021, Trends in biochemical sciences.

Griffithsin Retains Anti-HIV-1 Potency with Changes in gp120 Glycosylation and Complements Broadly Neutralizing Antibodies PGT121 and PGT126

P. LiWang, K. Nguyen, K. Fischer, 2019, Antimicrobial Agents and Chemotherapy.

The Griffithsin Dimer Is Required for High-Potency Inhibition of HIV-1: Evidence for Manipulation of the Structure of gp120 as Part of the Griffithsin Dimer Mechanism

J. Balzarini, B. Hoorelbeke, B. Demeler, 2013, Antimicrobial Agents and Chemotherapy.

Stabilization and Sustained Release of HIV Inhibitors by Encapsulation in Silk Fibroin Disks.

P. Ziprin, D. Kaplan, C. Herrera, 2017, ACS biomaterials science & engineering.

Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry*

R. Ptak, P. LiWang, M. Mankowski, 2011, The Journal of Biological Chemistry.

The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin.

J. Balzarini, B. Hoorelbeke, B. Demeler, 2012, Molecular pharmaceutics.

Sustained release silk fibroin discs: Antibody and protein delivery for HIV prevention

D. Kaplan, C. Herrera, B. Yavuz, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Chemokine-receptor interactions: solving the puzzle, piece by piece.

P. LiWang, Li Zhang, 2014, Structure.

CC chemokine MIP-1 beta can function as a monomer and depends on Phe13 for receptor binding.

M. Parmentier, J. Laurence, C. Blanpain, 2000, Biochemistry.

Efficacy of silk fibroin biomaterial vehicle for in vivo mucosal delivery of Griffithsin and protection against HIV and SHIV infection ex vivo

P. Ziprin, C. Herrera, A. Hessell, 2020, Journal of the International AIDS Society.

SARS-CoV-2 pseudotyped virus persists on the surface of multiple produce but can be inactivated with gaseous ozone

R. Ehsani, P. LiWang, L. Afsah-Hejri, 2022, Heliyon.

The Human CC Chemokine MIP-1β Dimer Is Not Competent to Bind to the CCR5 Receptor*

Hongjun Jin, Xiaohong Shen, P. LiWang, 2007, Journal of Biological Chemistry.

Investigation of CC and CXC chemokine quaternary state mutants.

Hongjun Jin, Garret L Hayes, P. LiWang, 2005, Biochemical and biophysical research communications.

Glycosaminoglycan disaccharide alters the dimer dissociation constant of the chemokine MIP-1 beta.

P. LiWang, Melissa A McCornack, Danielle M Boren, 2004, Biochemistry.

Characterization of the role of the N-loop of MIP-1β in CCR5 binding

M. Parmentier, C. Blanpain, A. Bondue, 2002 .

Effect of N-terminal truncation and solution conditions on chemokine dimer stability: nuclear magnetic resonance structural analysis of macrophage inflammatory protein 1 beta mutants.

J. Laurence, A. LiWang, P. LiWang, 1998, Biochemistry.

Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines

Timothy N. C. Wells, Tracy M. Handel, Patricia LiWang, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Importance of basic residues and quaternary structure in the function of MIP-1 beta: CCR5 binding and cell surface sugar interactions.

M. Parmentier, J. Laurence, C. Blanpain, 2001, Biochemistry.

Structural comparison of monomeric variants of the chemokine MIP-1beta having differing ability to bind the receptor CCR5.

J. Laurence, P. LiWang, S. Jao, 2001, Biochemistry.

The solution structure of the anti‐HIV chemokine vMIP‐II

A. LiWang, Zi-Xuan Wang, S. Peiper, 1999, Protein science : a publication of the Protein Society.

CC and CX3C Chemokines Differentially Interact with the N Terminus of the Human Cytomegalovirus-encoded US28 Receptor*

R. Leurs, T. Schwartz, P. Casarosa, 2005, Journal of Biological Chemistry.

Optimization of gene expression in nonactivated circulating lymphocytes.

N. Templeton, P. LiWang, U. Sili, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Biophysical and Computational Studies of the vCCI:vMIP-II Complex

M. Colvin, C. M. Dupureur, P. LiWang, 2017, International journal of molecular sciences.

A Comparison of 5P12-vMIP-II and vMIP-II as HIV-1 Entry Inhibitors

P. LiWang, Nai-Wei Kuo, J. Xue, 2013 .

Structural Insights into the Interaction between a Potent Anti-inflammatory Protein, Viral CC Chemokine Inhibitor (vCCI), and the Human CC Chemokine, Eotaxin-1*

N. Isern, C. M. Dupureur, P. LiWang, 2014, The Journal of Biological Chemistry.

Solution structure of the complex between poxvirus-encoded CC chemokine inhibitor vCCI and human MIP-1β

N. Isern, R. Moyer, P. LiWang, 2006, Proceedings of the National Academy of Sciences.

The Binding Surface and Affinity of Monomeric and Dimeric Chemokine Macrophage Inflammatory Protein 1β for Various Glycosaminoglycan Disaccharides* 210

P. LiWang, C. Cassidy, Melissa A McCornack, 2003, The Journal of Biological Chemistry.

Dynamics study on the anti-human immunodeficiency virus chemokine viral macrophage-inflammatory protein-II (VMIP-II) reveals a fully monomeric protein.

A. LiWang, Z. Lu, S. Peiper, 1999, Biochemistry.

Potent Strategy To Inhibit HIV-1 by Binding both gp120 and gp41

R. Ptak, P. LiWang, M. Mankowski, 2010, Antimicrobial Agents and Chemotherapy.

Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans.

P. LiWang, Bo Zhao, 2010, Biochemistry.

Structural and functional studies of the potent anti‐HIV chemokine variant P2‐RANTES

Hongjun Jin, Pingwei Li, P. LiWang, 2008, Proteins.

Characterization of the role of the N-loop of MIP-1 beta in CCR5 binding.

M. Parmentier, C. Blanpain, A. Bondue, 2002, Biochemistry.

Role of the Carbohydrate-Binding Sites of Griffithsin in the Prevention of DC-SIGN-Mediated Capture and Transmission of HIV-1

J. Balzarini, B. Hoorelbeke, P. LiWang, 2013, PloS one.

HIV‐1 envelope trimer has similar binding characteristics for carbohydrate‐binding agents as monomeric gp120

R. Sanders, J. Balzarini, Y. Igarashi, 2013, FEBS letters.

WITHDRAWN: Very strong synergy between modified RANTES and gp41 binding peptides leads to potent anti-HIV-1 activity.

Hongjun Jin, P. LiWang, R. Smith, 2008, Antimicrobial agents and chemotherapy.

Efficient production of fluorophore-labeled CC chemokines for biophysical studies using recombinant enterokinase and recombinant sortase.

C. M. Dupureur, M. Sadqi, Wenyan Guan, 2023, Biopolymers.

Sustained Delivery of the Antiviral Protein Griffithsin and Its Adhesion to a Biological Surface by a Silk Fibroin Scaffold

Wenyan Guan, P. LiWang, Arjan Bains, 2023, Materials.

The binding and specificity of chemokine binding proteins, through the lens of experiment and computation

M. Colvin, Wenyan Guan, P. LiWang, 2021, Biomedical journal.

Conservation of unfavorable sequence motifs that contribute to the chemokine quaternary state.

M. Vannucci, J. Tsai, Sinae Kim, 2008, Biochemistry.

Resonance Assignments and Secondary Structure of vCCI, a 26 kDa CC Chemokine Inhibitor from Rabbitpox Virus

P. LiWang, Li Zhang, M. DeRider, 2006, Journal of biomolecular NMR.

Potent Strategy To Inhibit HIV-1 by Binding both gp120 and gp41

R. Ptak, P. LiWang, M. Mankowski, 2010, Antimicrobial Agents and Chemotherapy.

The Effect of Select SARS-CoV-2 N-Linked Glycan and Variant of Concern Spike Protein Mutations on C-Type Lectin-Receptor-Mediated Infection

Wenyan Guan, P. LiWang, Arjan Bains, 2023, Viruses.

The Antiviral Activity of the Lectin Griffithsin against SARS-CoV-2 Is Enhanced by the Presence of Structural Proteins

Wenyan Guan, P. LiWang, Arjan Bains, 2023, Viruses.

The Griffithsin Dimer Is Required for High-Potency Inhibition of HIV-1: Evidence for Manipulation of the Structure of gp120 as Part of the Griffithsin Dimer Mechanism

J. Balzarini, B. Demeler, P. LiWang, 2013, Antimicrobial Agents and Chemotherapy.

Highly Potent Chimeric Inhibitors Targeting Two Steps of HIV Cell Entry*

R. Ptak, P. LiWang, M. Mankowski, 2011, The Journal of Biological Chemistry.